Literature DB >> 25215858

Premature ventricular contraction variability in arrhythmogenic right ventricular dysplasia/cardiomyopathy.

Christian F Camm1, Crystal Tichnell, Cynthia A James, Brittney Murray, Florence Porterfield, Anneline S J M Te Riele, Harikrishna Tandri, Hugh Calkins.   

Abstract

INTRODUCTION: Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) is an inherited cardiomyopathy, characterized by right ventricular dysfunction and ventricular arrhythmias. Premature ventricular contractions (PVCs) are an important measure in determining disease severity and constitute a minor criterion in the 2010 Task Force Criteria for the diagnosis of ARVD/C. Little information is available regarding the variability in PVCs. METHODS AND
RESULTS: Patients (n = 40) from the Johns Hopkins ARVD/C registry, meeting diagnostic criteria were included. Single lead continuous 12-lead electrocardiogram (ECG) monitors (Zio® Patches) were applied to monitor PVC counts. Detailed demographic, phenotypic, and structural information were obtained from registry data. ECG monitors were worn for a mean period of 159.3 hours (±39.3). Average 24-hour PVC count in this population was 1,090.5 (interquartile range = 1,711). One-way analysis of variance demonstrated statistically significant interday variance in mean hourly PVC counts in 76% of ARVD/C-positive subjects (28/37, 3 cases excluded due to insufficient data). Eleven individuals (27.5%) had maximum 24-hour PVC counts of >500 with a corresponding minimum 24-hour PVC count of <500. The average 24-hour PVC count for each patient was derived for each day recorded. The 24-hour PVC count placed 89.6% of counts (223/249) on the correct side of the 500-PVC count.
CONCLUSION: Statistically significant variation between 24-hour PVC counts is present in the ARVD/C population. However, 24-hour ECG monitoring was sufficient to identify 89.6% of 24-hour periods to the correct grouping based on 2010 Task Force Criteria.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  Holter; arrhythmogenic right ventricular dysplasia/cardiomyopathy; premature ventricular contractions; variability

Mesh:

Year:  2014        PMID: 25215858     DOI: 10.1111/jce.12544

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  3 in total

1.  2017 ISHNE-HRS expert consensus statement on ambulatory ECG and external cardiac monitoring/telemetry.

Authors:  Jonathan S Steinberg; Niraj Varma; Iwona Cygankiewicz; Peter Aziz; Paweł Balsam; Adrian Baranchuk; Daniel J Cantillon; Polychronis Dilaveris; Sergio J Dubner; Nabil El-Sherif; Jaroslaw Krol; Malgorzata Kurpesa; Maria Teresa La Rovere; Suave S Lobodzinski; Emanuela T Locati; Suneet Mittal; Brian Olshansky; Ewa Piotrowicz; Leslie Saxon; Peter H Stone; Larisa Tereshchenko; Mintu P Turakhia; Gioia Turitto; Neil J Wimmer; Richard L Verrier; Wojciech Zareba; Ryszard Piotrowicz
Journal:  Ann Noninvasive Electrocardiol       Date:  2017-05       Impact factor: 1.468

2.  Premature ventricular contraction-induced dilated cardiomyopathy: a case report.

Authors:  Jonathan Sen; John Amerena
Journal:  Eur Heart J Case Rep       Date:  2019-02-25

3.  Arrhythmogenic right ventricular cardiomyopathy: evaluation of the current diagnostic criteria and differential diagnosis.

Authors:  Domenico Corrado; Peter J van Tintelen; William J McKenna; Richard N W Hauer; Aris Anastastakis; Angeliki Asimaki; Cristina Basso; Barbara Bauce; Corinna Brunckhorst; Chiara Bucciarelli-Ducci; Firat Duru; Perry Elliott; Robert M Hamilton; Kristina H Haugaa; Cynthia A James; Daniel Judge; Mark S Link; Francis E Marchlinski; Andrea Mazzanti; Luisa Mestroni; Antonis Pantazis; Antonio Pelliccia; Martina Perazzolo Marra; Kalliopi Pilichou; Pyotr G A Platonov; Alexandros Protonotarios; Alessandra Rampazzo; Jeffry E Saffitz; Ardan M Saguner; Christian Schmied; Sanjay Sharma; Hari Tandri; Anneline S J M Te Riele; Gaetano Thiene; Adalena Tsatsopoulou; Wojciech Zareba; Alessandro Zorzi; Thomas Wichter; Frank I Marcus; Hugh Calkins
Journal:  Eur Heart J       Date:  2020-04-07       Impact factor: 29.983

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.